FDA Approval Obtained For Treating Mid Face Using Cannula
Galderma Laboratories, a medical solution provider in skin health, announced in November 2018 that it has received U.S. Food and Drug Administration (FDA) approval for the use of Restylane Lyft , one of their most popular Hyaluronic Acid (HA) dermal filler, with a cannula for cheek augmentation and the correction of age-related mid-face contour deficiencies in patients over the age of 21. For those who are unaware, a cannula is a thin, flexible tube with a small opening that provides an avenue for the delivery of fillers into the face. It can be done easily and with ease because of the malleability of the needle. “I am glad that the U.S. FDA has approved the use of cannula to deliver Restylane Lyft for mid-face augmentation. I have always preferred to use cannula to deliver fillers especially in sensitive, hard-to-reach areas,” said Dr. Siew Tuck Wah , one of the leading aesthetic doctors in Singapore . Dr. Siew Tuck Wah, Medical Director of Radium Medical Aesthetics